Costa Rican Scientists Make Progress in Road to Finding Treatment for Coronavirus

The Clodomiro Picado Institute of the University of Costa Rica created its first test lot with plasma on patients that have NOT had Covid-19, which helps verify its line of productions to process the plasma of Covid-19 convalescent patients.

What this means is that the Institute now is completely prepared to receive the plasma from Covid-19 convalescent patients when the Social Security Service (CCSS) sends it. This will allow the production of purified and condensed immunoglobulins.

The Clodomiro Picado Institute (ICP-UCR) is known for its production of high-quality antivenoms for victims of snakebites which are used in different regions of Latin America, Africa, Oceania and Sri Lanka.

“The work of these past few weeks has been focused on the production of antivenoms with the purpose of filling out our storage with enough product to satisfy demand. This will give us space and clears out clean room agenda with the idea of processing the plasma in the moment the CCSS sends it”, explained Dr. Guillermo León, coordinator of the Industrial Division of ICP-UCR.

Read more here:

Leave a Comment